27 October 2025 As IP plays a more important role in corporate valuations, acquirers are discovering that the biggest risks ...

Merck Serono has failed to convince a US appeals court to overturn a PTAB decision invalidating two dosing regimen patents ...

The best use of AI can—in the most extreme cases—mean the difference between life and death, according to Carol Fang, global head of IP platforms at Novartis. Already registered? If you don't have a ...

17 October 2025 A US Senate subcommittee hearing on patent eligibility reform has David Kappos, former USPTO director, believing that “there’s a better chance than ever” of a pending bill becoming law ...

Rising patent litigation over rare disease treatments highlights the success of the Hatch-Waxman and Orphan Drug Acts, says ...

11 March 2025 The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another ...

22 October 2025 Just weeks into his tenure, USPTO director John Squires is blitzing US patent policy by taking control of how ...

25 September 2025 A new survey from LSIPR reveals that European patent practitioners are grappling with client budget constraints and fast-evolving technologies, with most expecting patenting ...

East IP, in the ‘Highly Recommended’ category, handles trademark work in China for Ticketmaster’s parent company Live Nation ...

A US appeals court had good news for the California-based medtech company in a dispute over its Sapien 3 Ultra transcatheter heart valve.

As IP plays a more important role in corporate valuations, acquirers are discovering that the biggest risks in life sciences ...

Parties impacted by exclusion orders need to carefully weigh their options for seeking clarity or rulings on redesigns, ...